EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 161 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $579,000 | +12.6% | 18,349 | +0.4% | 0.02% | +7.1% |
Q2 2016 | $514,000 | -17.2% | 18,271 | +6.9% | 0.01% | -6.7% |
Q1 2016 | $621,000 | +18.1% | 17,086 | +30.1% | 0.02% | +15.4% |
Q4 2015 | $526,000 | +40.3% | 13,136 | -0.1% | 0.01% | +44.4% |
Q3 2015 | $375,000 | -43.9% | 13,151 | -35.1% | 0.01% | -40.0% |
Q2 2015 | $668,000 | -83.9% | 20,272 | -86.0% | 0.02% | -84.0% |
Q1 2015 | $4,160,000 | -55.5% | 144,658 | -57.8% | 0.09% | -55.5% |
Q4 2014 | $9,343,000 | +46.1% | 343,102 | +14.3% | 0.21% | +42.6% |
Q3 2014 | $6,395,000 | +69.6% | 300,080 | +78.8% | 0.15% | +64.4% |
Q2 2014 | $3,770,000 | -59.7% | 167,836 | -54.7% | 0.09% | -19.6% |
Q1 2014 | $9,362,000 | +9.6% | 370,462 | -0.3% | 0.11% | +12.0% |
Q4 2013 | $8,540,000 | +134.4% | 371,432 | +94.2% | 0.10% | +11.1% |
Q3 2013 | $3,644,000 | +38.0% | 191,311 | +4.5% | 0.09% | +28.6% |
Q2 2013 | $2,640,000 | – | 183,075 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |